These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31648379)

  • 1. Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
    Martini DJ; Kline MR; Liu Y; Shabto JM; Williams MA; Khan AI; Lewis C; Collins H; Akce M; Kissick HT; Carthon BC; Shaib WL; Alese OB; Pillai RN; Steuer CE; Wu CS; Lawson DH; Kudchadkar RR; El-Rayes BF; Ramalingam SS; Owonikoko TK; Harvey RD; Master VA; Bilen MA
    Cancer; 2020 Feb; 126(3):575-582. PubMed ID: 31648379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.
    Esposito A; Marra A; Bagnardi V; Frassoni S; Morganti S; Viale G; Zagami P; Varano GM; Buccimazza G; Orsi F; Venetis K; Mazzarella L; Viale G; Fusco N; Criscitiello C; Curigliano G
    Eur J Cancer; 2021 Mar; 145():197-209. PubMed ID: 33493979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S; Goldman JM; Nazha B; Kissick HT; Harris WB; Kucuk O; Carthon BC; Master VA; Bilen MA
    Front Oncol; 2021; 11():707050. PubMed ID: 34307176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
    Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
    Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer.
    Slaughter KN; Thai T; Penaroza S; Benbrook DM; Thavathiru E; Ding K; Nelson T; McMeekin DS; Moore KN
    Gynecol Oncol; 2014 Apr; 133(1):11-5. PubMed ID: 24680585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
    Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L; Russler GA; Caulfield S; Goldman JM; Nazha B; Joshi SS; Kissick HT; Ogan KE; Harris WB; Kucuk O; Carthon BC; Master VA; Bilen MA
    Oncologist; 2021 Dec; 26(12):1017-1025. PubMed ID: 34342095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma.
    Ishihara H; Nishimura K; Ikeda T; Fukuda H; Yoshida K; Iizuka J; Kondo T; Takagi T
    Urol Oncol; 2024 Sep; 42(9):291.e27-291.e37. PubMed ID: 38653590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study.
    Lee JH; Hyung S; Lee J; Choi SH
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
    Martini DJ; Liu Y; Shabto JM; Lewis C; Kline MR; Collins H; Akce M; Kissick HT; Carthon BC; Shaib WL; Alese OB; Pillai RN; Steuer CE; Wu CS; Lawson DH; Kudchadkar RR; Master VA; El-Rayes BF; Ramalingam SS; Owonikoko TK; Harvey RD; Bilen MA
    Invest New Drugs; 2019 Dec; 37(6):1198-1206. PubMed ID: 30725388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.
    Kichenadasse G; Miners JO; Mangoni AA; Rowland A; Hopkins AM; Sorich MJ
    JAMA Oncol; 2020 Apr; 6(4):512-518. PubMed ID: 31876896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
    Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Steuer CE; Wu C; Lawson DH; Kudchadkar R; Master VA; El-Rayes B; Ramalingam SS; Owonikoko TK; Harvey RD
    BMC Cancer; 2019 Aug; 19(1):857. PubMed ID: 31464611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.
    Lee S; Kim JH; Song W; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Park SH; Lee JH; Yu J; Kang M
    Cancer Manag Res; 2024; 16():1091-1101. PubMed ID: 39220816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
    Makrakis D; Rounis K; Tsigkas AP; Georgiou A; Galanakis N; Tsakonas G; Ekman S; Papadaki C; Monastirioti A; Kontogianni M; Gioulbasanis I; Mavroudis D; Agelaki S
    PLoS One; 2023; 18(2):e0277708. PubMed ID: 36763597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.
    Gómez-Banoy N; Ortiz EJ; Jiang CS; Dagher C; Sevilla C; Girshman J; Pagano AM; Plodkowski AJ; Zammarrelli WA; Mueller JJ; Aghajanian C; Weigelt B; Makker V; Cohen P; Osorio JC
    J Clin Invest; 2024 Jun; 134(17):. PubMed ID: 38900575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
    Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
    JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional association between perioperative skeletal muscle and subcutaneous fat in colorectal cancer patients and their prognostic significance.
    Yan G; Liu L; Liu M; Jiang X; Chen P; Li M; Ma Q; Li Y; Duan S; You R; Huang Y; Li Z; You D
    Front Nutr; 2024; 11():1381995. PubMed ID: 39360277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
    Bilen MA; Martini DJ; Liu Y; Lewis C; Collins HH; Shabto JM; Akce M; Kissick HT; Carthon BC; Shaib WL; Alese OB; Pillai RN; Steuer CE; Wu CS; Lawson DH; Kudchadkar RR; El-Rayes BF; Master VA; Ramalingam SS; Owonikoko TK; Harvey RD
    Cancer; 2019 Jan; 125(1):127-134. PubMed ID: 30329148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition in relation to postoperative anastomotic leakage and overall survival in patients with esophageal cancer.
    Li S; Qiu R; Yuan G; Wang Q; Li Z; Li Q; Zhang N
    Nutrition; 2022 Feb; 94():111534. PubMed ID: 34952360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition.
    Naik GS; Waikar SS; Johnson AEW; Buchbinder EI; Haq R; Hodi FS; Schoenfeld JD; Ott PA
    J Immunother Cancer; 2019 Mar; 7(1):89. PubMed ID: 30922394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.